dc.contributor.author |
Akhmedov Kh.S., Rakhimova M.B. |
|
dc.date.accessioned |
2024-12-16T19:09:51Z |
|
dc.date.available |
2024-12-16T19:09:51Z |
|
dc.date.issued |
2024 |
|
dc.identifier.citation |
Toshkent |
en_US |
dc.identifier.issn |
2181-7812 |
|
dc.identifier.uri |
http://repo.tma.uz/xmlui/handle/1/366 |
|
dc.description.abstract |
80 patients diagnosed with ankylos- ing spondylitis were examined and were treated at the rheu- matology department of the Tashkent Clinical Hospital: Group 1 - 40 patients with ankylosing spondylitis without a post- COVID period, Group 2 - 40 patients with ankylosing spon- dylitis and a post-COVID period. The control group consisted of 40 healthy people without a history of acute and chronic diseases. Results: A study of the functional state of the endo- thelium with a reactive hyperemia test showed a decrease in the diameter of the brachial artery from the expected value 60 and 120 seconds after decompression, as well as an increase in maximum systolic and a decrease in maximum diastolic blood flow in the main group. Conclusions: The results of the exam- ination indicate a violation of the resistance of the vascular wall against the background of endothelial dysfunction. |
en_US |
dc.language.iso |
en |
en_US |
dc.relation.ispartofseries |
UDC;616-008:616.13-02:612.017.1-616-074-08 |
|
dc.subject |
ankylosing spondylitis, COVID-19, endo- thelial dysfunction. |
en_US |
dc.title |
Impared endothelial dysfunction in patients with ankylosing spondylitis |
en_US |
dc.type |
Article |
en_US |